Lot certificates published
Plain, secure packaging

Compound monograph

Apelin-13 (unmodified)

Apelin-13 is a 13-residue peptide with an N-terminal glutamine and a C-terminal phenylalanine. This record describes the unmodified parent with free terminal groups.

Published: 2026-10-21Literature/identifier verification: 2026-10-21

01

Identity & nomenclature

Apelin-13 is a 13-residue peptide with an N-terminal glutamine and a C-terminal phenylalanine. This record describes the unmodified parent with free terminal groups.

This record specifies the unmodified free-terminal parent. Pyroglutamyl and amidated forms are distinct chemistry and are excluded as aliases. CAS and UNII are withheld under the dossier issuer-evidence limits.

Canonical name: Apelin-13.

02

Molecular properties

Molecular formulaC69H111N23O16S
Molecular mass1550.852 Da
PubChem CID25078060
One-letter sequenceQRPRLSHKGPMPF
Three-letter sequenceGln–Arg–Pro–Arg–Leu–Ser–His–Lys–Gly–Pro–Met–Pro–Phe
Terminal groupsFree N-terminus; Free C-terminal carboxyl

Positions count the mature chain from 1. All chiral amino-acid residues are L; glycine is achiral. Terminal groups are recorded separately.

03

Structural characteristics

The chain contains standard L-amino-acid residues and no inter-residue covalent closure.

Terminal features: Free N-terminus, Free C-terminal carboxyl.

04

Molecular targets & mechanisms

05

Analytical considerations

The molecular formula describes the parent; the average mass is calculated using CIAAW 2024 abridged atomic weights. PubChem reports 1550.8: +0.052 Da (+33.531 ppm), a mismatch as printed and a non-defining registry number. Published theoretical and observed analytical numbers retain their source conventions; no ion assignment is inferred.

What the studies reported

No verified findings are published for this record under Content Policy v1.

06

Verified bibliography

Cited studies by type

The 3 papers this record cites, counted by the kind of work each reports. A count is the size of this record's selection, not of the research that exists, and says nothing about results, safety, effectiveness or approval.

A paper can report more than one kind of work. Each count opens those papers in the bibliography. Compare every record on the Evidence Map.

  1. Reference 1

    Bicelle composition-dependent modulation of phospholipid dynamics by apelin peptides (1).

    Sarker M, Speckert M, Rainey JK

    Biochemistry and cell biology = Biochimie et biologie cellulaire · 2018-08-09 · Journal Article

    current
  2. Reference 2

    Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions.

    O'Harte FPM, Parthsarathy V, Hogg C, Flatt PR

    Peptides · 2018-02 · Journal Article

    current
  3. Reference 3

    The G protein-coupled receptor ligand apelin-13 ameliorates skeletal muscle atrophy induced by chronic kidney disease.

    Enoki Y, Nagai T, Hamamura Y, Osa S, Nakamura H, Taguchi K, Watanabe H, Maruyama T, Matsumoto K

    Journal of cachexia, sarcopenia and muscle · 2022-12-23 · Journal Article

    current

Study models of these references

What kind of experiment each cited paper reports, taken from its abstract unless marked. Not a summary of results.

ReferenceStudy models
Sarker M et al. 2018Chemical, structural or analytical study; no biological model reported
O'Harte FPM et al. 2018Study models reported: in vitro; animal (mouse) · from the abstract
Enoki Y et al. 2022Study models reported: in vitro; animal (mouse) · from the abstract

Record history

Published 2026-10-21.

No changes to this record's content have been recorded since publication.

Each entry names the parts of this record that changed on that date. Changes to links between records and to catalogue links are not listed. This history covers the tracked record fields; study findings are not listed here.

Cite this record: Purely Peptides Research Library. Apelin-13 (unmodified). Published 2026-10-21. https://purelypeptides.org/research/compounds/apelin-13/

10

Methodology & citation verification

Reference identity is checked against official PubMed metadata. Local deterministic receipts bind each normalized title and canonical metadata record to its verification date. Scientific values remain absent when an authoritative source has not been verified.

Read the full methodology →